Innovations in Management of Pancreatic Conditions and Therapies: The Mayo Clinic IMPACT Course 2023
This course has already taken place. You may be interested in the 2024 Innovations in Management of Pancreatic Conditions and Therapies: The Mayo Clinic IMPACT Course
This course offers Live (in-person) and Livestream (virtual) attendance options
Course Director: Vinay Chandrasekhara, M.D.
April 21, 2023 - Live (In Person, Rochester, Minnesota) and Livestream - Central Time (CT)
Mayo Clinic is one of the largest medical centers in the country dedicated to the management of pancreatic diseases, and a pioneer in the management of pancreatic conditions ranging from benign to malignant. Thus, Mayo Clinic created this one-day course with pancreas experts to highlight the recent innovations in the management of pancreatic conditions and the therapies that can be incorporated into clinical practice. This virtual, livestream course allows for interaction with the speakers.
The 2023 Innovations in Management of Pancreatic Conditions and Therapies: The Mayo Clinic IMPACT Course will feature a poster session with the goal of sharing knowledge, showcasing participants’ work, and stimulating dialogue among course attendees. All approved posters will be virtually displayed to course attendees.
Posters can feature interesting cases, data-driven original research, describe innovative clinical programs or projects related to the assessment and treatment of any aspect of pancreas-related cases. The top 5 posters related to interesting cases/case reports or series will be invited to orally present their poster at the live course. Participants are encouraged to submit projects highlighting programs and initiatives that impact the practice, education, research, and administrative environments in health care, and abstracts that provide evidence and successful models for engaging targeted stakeholders and constituents and advancing health care delivery.
We invite you to take advantage of the unique opportunity and submit an abstract to be presented as a poster during the 2023 Innovations in Management of Pancreatic Conditions and Therapies: The Mayo Clinic IMPACT Course. Abstract submissions are now closed.
Scholarship Opportunity for GI Fellows
Up to 15 scholarships will be awarded to GI fellows to attend this course. Those interested in receiving a scholarship are required to submit an essay explaining the importance and relevance of this course to their fellowship. Essays will be reviewed and scholarship recipients determined by the course director. The scholarship will cover the entire cost of the course. Scholarship submissions are now closed.
Gastroenterologists, internal medicine physicians, nurse practitioners, and trainees (medical students, residents, fellows).
Upon completion of this activity, participants should be able to:
- Identify which patients qualify for pancreatic cancer screening.
- Summarize how to screen for pancreatic cancer.
- Identify patients with pancreatic cystic lesions that have high-risk stigmata or worrisome features that require additional investigation.
- Determine need for surveillance in patients with low-risk pancreatic cysts.
- Describe best-practice initial management of patients presenting with acute pancreatitis.
- Recognize complications of acute pancreatitis, including development of symptomatic pseudocysts and walled-off necrosis.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
All travel and lodging expenses are the sole responsibility of the individual registrant.
Mayo Clinic Faculty
Yan Bi, M.D., Ph.D.
Aliana M. Bofill-Garcia, M.D.
Vinay Chandrasekhara, M.D.
Ajit H. Goenka, M.D.
Thorvardur (Thor) R. Halfdanarson, M.D.
Krishan R. Jethwa, M.D.
Ryan J. Law, D.O.
Shounak Majumder, M.D.
Mark J. Truty, M.D., M.S.
John A. Martin, M.D.
Motaz Ashkar, M.D. MSCI
Rupjyoti Talukdar, M.D.
Asian Healthcare Foundation
Neil Marya, M.D.
University of Massachusetts
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 7.25 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
- 7.25 ABIM
- 7.25 AMA PRA Category 1 Credit™
- 7.25 ANCC
- 7.25 Attendance
This course offers the unique opportunity for commercial companies to interact with healthcare providers and highlight their products and services. Please see the following information if you are interested in exhibiting at or sponsoring this course:
Sponsorship Prospectus (PDF)
This activity is supported in part by educational & in-kind grants from the
following companies in accordance with ACCME Standards:
Olympus America Inc.